Pediatric uses of fluoroquinolone antibiotics

Pediatric Annals

Volumn 36, Issue 6, 2007, Pages 336-342

  Murray, Thomas S ^a   Baltimore, Robert S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; ENOXACIN; FLEROXACIN; GATIFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ACUTE OTITIS MEDIA; ANTHRAX; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTHRALGIA; BLOODY DIARRHEA; CHONDROPATHY; DEVELOPMENTAL DISORDER; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; GASTROENTERITIS; GLUCOSE BLOOD LEVEL; GRAM NEGATIVE SEPSIS; HUMAN; HYPOGLYCEMIA; INSOMNIA; LIVER FAILURE; MENINGITIS; MYALGIA; MYCOBACTERIOSIS; NEUTROPENIA; OFF LABEL DRUG USE; OSTEOMYELITIS; PHOTOSENSITIVITY; PSEUDOMEMBRANOUS COLITIS; QT INTERVAL; RASH; RESPIRATORY TRACT INFECTION; REVIEW; SIDE EFFECT; TENDINITIS; THINKING; URINARY TRACT INFECTION;

EID: 34347269572     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20070601-09     Document Type: Review

References (27)

1. Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM. Quinolones in 2005: an update. Clin Microbiol Infect. 2005;11(4):256-280.
2. Burkhardt JE, Walterspiel JN, Schaad UB. Quinolone arthropathy in animals versus children. Clin Infect Dis. 1997;25(5):1196-1204.
3. Fedler KA, Biedenbach DJ, Jones RN. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: Report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. Diagn Microbiol Infect Dis. 2006;56(4):427-436.
4. Echols R, Hamed K, Arguedas A, et al. Gatifloxacin therapy for children: turn on the light. Clin Infect Dis. 2005;41(12):1824-1825.
5. Mandell LA, Peterson LR, Wise R, et al. The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis. 2002;35(6):721-727.
6. Committee on Infectious Diseases. The use of systemic fluoroquinolones. Pediatrics. 2006;118(3):1287-1292.
7. Yee CL, Duffy C, Gerbino PG, Stryker S, Noel GJ. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. Pediatr Infect Dis J. 2002;21(6):525-529.
8. Grady R. Safety profile of quinolone antibiotics in the pediatric population. Pediatr Infect Dis J. 2003;22(12):1128-1132.
9. Chalumeau M, Tonnelier S, D'Athis P, et al, and the Pediatric Fluoroquinolone Safety Study Investigators. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics 2003;111(6 Pt 1):e714-719.
10. van den Oever HL, Versteegh FG, Thewessen EA, van den Anker JN, Mouton JW, Neijens HJ. Ciprofloxacin in preterm neonates: case report and review of the literature. Eur J Pediatr. 1998;157(10):843-845.
11. Ahmed AS, Khan NZ, Saha SK, et al. Ciprofloxacin treatment in preterm neonates in Bangladesh: lack of effects on growth and development. Pediatr Infect Dis J. 2006;25(12):1137-1141.
12. Loebstein R, Addis A, Ho E, et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a mulficenter prospective controlled study. Antimicrob Agents Chemother. 1998;42(6):1336-1339.
13. Wogelius P, Norgaard M, Gislum M, Pedersen L, Schonheyder HC, Sorensen HT. Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones. Int J Antimicrob Agents. 2005;26(4):323-326.
14. Arguedas A, Sher L, Lopez E, et al. Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure. Pediatr Infect Dis J. 2003;22(11):949-956.
15. Frothingham R. Glucose homeostasis abnormalities associated with use of gatifloxacin. Clin Infect Dis. 2005;41(9):1269-1276.
16. Owens RC, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005;41(Suppl 2):144-157.
17. Angel CA, Green J, Swischuk L, Patel J. Severe ciprofloxacin-associated pseudomembranous colitis in an eight-year-old child. J Pediatr Surg. 2004;39(10):1590-1592.
18. Arguedas A, Dagan R, Pichichero M, Leibovitz E, Blumer JL, McNeeley DF, et al. An open label, double tympanocentesis study of levofloxacin therapy in children with or at high risk for, recurrent or persistent otitis media. Pediatr Infect Dis J. 2006;25(12):1102-1109.
19. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005;41(Suppl 2):120-126.
20. Gay K, Robicsek A, Strahilevitz J, et al. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis. 2006;43(3):297-304.
21. Powis J, McGeer A, Green K, et al, and the Canadian Bacterial Surveillance Network. In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother. 2004;48(9):3305-3311.
22. Karlowsky JA, Thornsberry C, Critchley IA, Jones ME, Evangelista AT, Noel GJ, et al. Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. Antimicrob Agents Chemother. 2003;47(6):1790-1797.
23. Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India. Trans R Soc Trop Med Hyg. 2007;101(3):308-310.
24. Qin X, Razia Y, Johnson JR, et al. Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children. Antimicrob Agents Chemother. 2006;50(10):3325-3329.
25. Meyerhoff A, Albrecht R, Meyer JM, Dionne P, Higgins K, Murphy D. U.S. Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax. Clin Infect Dis. 2004;39(3):303-308.
26. Koyle MA, Barqawi A, Wild J, Passamaneck M, Furness PD. Pediatric urinary tract infections: the role of fluoroquinolones. Pediatr Infect Dis J. 2003;22(12):1133-1137.
27. Mullen CA. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J. 2003;22(12):1138-1142.